|
NL130088C
(cg-RX-API-DMAC7.html)
|
1960-03-14 |
|
|
|
|
GB9420763D0
(en)
|
1994-10-14 |
1994-11-30 |
Glaxo Inc |
Acetamide derivatives
|
|
GB9919776D0
(en)
|
1998-08-31 |
1999-10-27 |
Zeneca Ltd |
Compoujnds
|
|
AU7961300A
(en)
|
1999-10-29 |
2001-05-14 |
Yamanouchi Pharmaceutical Co., Ltd. |
Kainic acid neurocytotoxicity inhibitors
|
|
AU2001262185A1
(en)
|
2000-04-10 |
2001-10-23 |
Novartis Ag |
Substituted (hetero)aryl carboxamide derivatives as microsomal triglyceride transfer protein (mtp) and apolipoprotein b (apo b) secretion
|
|
WO2002062389A1
(en)
|
2001-02-08 |
2002-08-15 |
Ono Pharmaceutical Co., Ltd. |
Remedies for urinary diseases comprising lpa receptor controlling agents
|
|
TW200403058A
(en)
*
|
2002-04-19 |
2004-03-01 |
Bristol Myers Squibb Co |
Heterocyclo inhibitors of potassium channel function
|
|
US7435824B2
(en)
|
2002-04-19 |
2008-10-14 |
Bristol-Myers Squibb Company |
Prodrugs of potassium channel inhibitors
|
|
TW200505902A
(en)
|
2003-03-20 |
2005-02-16 |
Schering Corp |
Cannabinoid receptor ligands
|
|
WO2004110350A2
(en)
|
2003-05-14 |
2004-12-23 |
Torreypines Therapeutics, Inc. |
Compouds and uses thereof in modulating amyloid beta
|
|
WO2005023761A2
(en)
|
2003-09-11 |
2005-03-17 |
Kemia, Inc. |
Cytokine inhibitors
|
|
JPWO2005037269A1
(ja)
|
2003-10-21 |
2006-12-28 |
住友製薬株式会社 |
新規ピペリジン誘導体
|
|
EP1687296A1
(en)
|
2003-11-18 |
2006-08-09 |
Warner-Lambert Company LLC |
Antibacterial aminoquinazolidinedione derivatives
|
|
WO2006091862A2
(en)
|
2005-02-24 |
2006-08-31 |
Kemia, Inc. |
Cytokine inhibitors and their use in therapy
|
|
CN101198590B
(zh)
|
2005-08-24 |
2012-05-09 |
卫材R&D管理有限公司 |
吡啶衍生物及嘧啶衍生物（3）
|
|
WO2007058990A2
(en)
|
2005-11-14 |
2007-05-24 |
Kemia, Inc. |
Therapy using cytokine inhibitors
|
|
CA2691214A1
(en)
|
2006-06-09 |
2007-12-21 |
Kemia, Inc. |
Therapy using cytokine inhibitors
|
|
JP5164510B2
(ja)
|
2006-10-06 |
2013-03-21 |
日本曹達株式会社 |
含窒素複素環化合物および有害生物防除剤
|
|
WO2008115281A2
(en)
|
2006-10-16 |
2008-09-25 |
Myriad Genetics, Inc. |
Compounds for treating viral infections
|
|
EP2212322B1
(en)
|
2007-10-18 |
2012-04-04 |
Merck Sharp & Dohme Corp. |
Quinolizidinone m1 receptor positive allosteric modulators
|
|
AU2009239500B2
(en)
|
2008-04-21 |
2014-01-30 |
Lexicon Pharmaceuticals, Inc. |
LIMK2 inhibitors, compositions comprising them, and methods of their use
|
|
PT2303270T
(pt)
|
2008-05-05 |
2017-08-25 |
Sanofi Sa |
Derivados fundidos do ácido ciclopentanocarboxílico substituídos por acilamino e sua utilização como produtos farmacêuticos
|
|
UY32072A
(es)
|
2008-08-26 |
2010-03-26 |
Boehringer Ingelheim Int |
Tienopirimidinas para composiciones farmacéuticas
|
|
KR101678255B1
(ko)
*
|
2009-09-25 |
2016-11-21 |
아스텔라스세이야쿠 가부시키가이샤 |
치환 아미드 화합물
|
|
ES2682303T3
(es)
|
2010-08-05 |
2018-09-19 |
Zoetis Services Llc |
Derivados de isoxazolina como agentes antiparasitarios
|
|
TW201305178A
(zh)
|
2010-10-29 |
2013-02-01 |
Glenmark Pharmaceuticals Sa |
作為ｍＰＧＥＳ－１抑制物的三環化合物
|
|
DK2648726T3
(da)
|
2010-12-07 |
2018-07-16 |
Amira Pharmaceuticals Inc |
Polycyklisk lpa1-antagonist og anvendelser deraf
|
|
JP6097998B2
(ja)
|
2010-12-16 |
2017-03-22 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
ロイコトリエン生成のビアリールアミドインヒビター
|
|
PH12013501831B1
(en)
|
2011-03-10 |
2019-06-14 |
Zoetis Services Llc |
Spirocyclic isoxazoline derivatives as antiparasitic agents
|
|
CA2859965A1
(en)
|
2011-12-21 |
2013-06-27 |
Ardelyx, Inc. |
Non-systemic tgr5 agonists
|
|
WO2014079805A1
(en)
|
2012-11-23 |
2014-05-30 |
Boehringer Ingelheim International Gmbh |
Pyrazole compounds for treating hairloss
|
|
EP2970200A1
(en)
*
|
2013-03-13 |
2016-01-20 |
Abbvie Inc. |
Pyridine cdk9 kinase inhibitors
|
|
AR108185A1
(es)
|
2016-04-06 |
2018-07-25 |
Abbvie Inc |
Amidas terciarias y método para su uso
|
|
AR119162A1
(es)
|
2019-06-18 |
2021-12-01 |
Idorsia Pharmaceuticals Ltd |
Derivados de piridin-3-ilo
|
|
JP7665619B2
(ja)
|
2019-12-04 |
2025-04-21 |
イドルシア・ファーマシューティカルズ・リミテッド |
線維性疾患の治療に使用するためのアゼチジンｌｐａ１受容体アンタゴニストのピルフェニドン及び／又はニンテダニブとの合剤
|